1Schewertner HA, Jackson WG, Tolan G. Association of low serumconcentration of bilirubin with increased risk of coronary artery disease. Clin Chem, 1994,40( 1 ) : 18-20.
1[1]Hopkins PN, Wu SC, Hunt BC, et al. Higher serum bilirulin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol, 1996, 16:250-255
2[2]Mayer M. Association of serm bilirubin concentration with risk of coronary artery disease. Clin Chem,2000,46:1723-1727
3[3]Mary S, Ayrs S, Humphrie S, et al. Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men. Am J Med,2001, 110(1):22-27
4[4]Von Eckardstein, Schulte H, Cullen P, et al. Lipoprotein (a)farther increase the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol, 2001,37(2) :434-439
5[5]Schwertner HA, Jackson WG, Tolan G. Association of concentration of bilirubin with increased risk of coronary artery disease.Clin Chem, 1994,40:18-23
6[6]Nakayama M, Takalash K, Komaru T, et al. Increased expression of heme oxygenase-1 and bilirubin accumalation in foam cell of rabit atherosclerotic lesions. Arteroscler Thromb Vasc Biol, 2001,21 (8): 1373-1377
7[7]Buechler C, Vllrich H. Lipoprotein (a) up -regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes. Blood, 2001,97 (4): 981-986
8Stocker R,Yamanoto Y,Mcdonagh A F,et al. Bilirubin is an antioxidant of possible physiological importance [ J ]. Science, 1987,235 (4792) : 1043-1046.
9Schwertner H A ,Jackson W G,Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease [J]. Clin Chem,1994,40(1) :18-23.
10Schwertner H A. Bilirubin concentration, UGT1A1 * 28 polymorphism, and coronary artery .disease [ J ]. Clinical Chemistry, 2003,49(7) : 1039-1040.
